🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

24+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 24 recruiting trials for “myeloid-sarcoma

Phase 1RecruitingNCT07222735

Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas

👨‍⚕️ Rebecca Epperly, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Jan 2026View details ↗
Phase 2RecruitingNCT07359053

MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma

🏥 Shanghai 6th People's Hospital📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07089992

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

👨‍⚕️ Robert Maki, MD, MPH, Memorial Sloan Kettering Cancer Center📍 6 sites📅 Started Dec 2025View details ↗
RecruitingNCT07215611

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

👨‍⚕️ Shalin S Patel, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Sep 2025View details ↗
RecruitingNCT06958107

LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients

👨‍⚕️ Johann Hsu, MD, Wake Forest University Health Sciences📍 2 sites📅 Started Aug 2025View details ↗
Phase 1, PHASE2RecruitingNCT07066982

Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas

🏥 Essen Biotech📍 1 site📅 Started May 2025View details ↗
NARecruitingNCT06796543

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

👨‍⚕️ Sahaja Acharya, MD, SKCCC Johns Hopkins Medical Institution📍 2 sites📅 Started Mar 2025View details ↗
Phase 1, PHASE2RecruitingNCT06709495

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

👨‍⚕️ David Shulman, MD, Dana-Farber Cancer Institute📍 3 sites📅 Started Jan 2025View details ↗
RecruitingNCT06409013

Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma

👨‍⚕️ Matthew T. Houdek, M.D., Mayo Clinic in Rochester📍 1 site📅 Started Mar 2024View details ↗
EARLY_Phase 1RecruitingNCT05851456

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors

🏥 Shanghai Yunying Medical Technology📍 1 site📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT04515459

Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma

🏥 Institut Claudius Regaud📍 1 site📅 Started Sep 2022View details ↗
NARecruitingNCT05051059

Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients

👨‍⚕️ Hazem Wafa, Universitaire Ziekenhuizen KU Leuven📍 1 site📅 Started Oct 2021View details ↗
Phase 2RecruitingNCT04698785

Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

👨‍⚕️ Mehdi BRAHMI, Centre Léon Bérard, Lyon📍 16 sites📅 Started Jul 2021View details ↗
Phase 1, PHASE2RecruitingNCT04390737

Evaluate the Safety and Clinical Activity of HH2853

👨‍⚕️ Fugen Li, Haihe Biopharma Co., Ltd.📍 25 sites📅 Started Sep 2020View details ↗
Phase 2RecruitingNCT04072042

BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma

👨‍⚕️ Weibin Zhang, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Oct 2019View details ↗
RecruitingNCT04300257

Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care

👨‍⚕️ Bruno Fuchs, Prof, SwissSarcomaNetwork📍 8 sites📅 Started Oct 2019View details ↗
RecruitingNCT05373810

Registration Study Sarcoma

🏥 Radboud University Medical Center📍 2 sites📅 Started Jul 2019View details ↗
RecruitingNCT04758325

The Sarcoma Biology and Outcome Project

👨‍⚕️ Richard F. Schlenk, Prof.Dr.med, National Center for Tumour Disease📍 1 site📅 Started Jul 2019View details ↗
RecruitingNCT04181970

Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK

👨‍⚕️ Javier MARTIN-BROTO, MD, Salud de Madrid📍 9 sites📅 Started Jun 2019View details ↗
RecruitingNCT04122872

GISAR German Interdisciplinary Sarcoma Registry

👨‍⚕️ Salah-Eddin Al-Batran, Prof. Dr, Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest📍 21 sites📅 Started Nov 2018View details ↗
Page 1 of 2Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →